Severe hypoglycemia in diabetics with impaired renal function;Schwere hypoglykämien bei diabetikern mit eingeschränkter nierenfunktion

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 6, 2003, Pages 253-256

  Hasslacher, C ^a,b   Wittmann, W ^b  

^a Abteilung Innere Medizin   (Germany)

^b StJosefs Krankenhaus Heidelberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIQUIDONE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCONEOGENESIS; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY FUNCTION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; CREATININE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; MALE; MIDDLE AGED; MODELS, THEORETICAL; SEX FACTORS;

EID: 0037423530     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37077     Document Type: Article

References (23)

1. Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am 1989; 18: 103-121
2. Asplund K, Wiholm BE, Lithner F. Glibenclamide-associated hypoclycaemia: a report on 57 cases. Diabetologia 1983; 24: 412-417
3. Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y. Drug-induced hypoclycemia coma in 102 diabetic patients. Arch Intern Med 1999; 159: 281-384
4. Cersosimo E, Garlick P, Ferretti J. Renal glucose production during insulin-induced hypoclycemia in humans. Diabetes 1999; 48: 261-266
5. Cersosimo E, Garlick P, Ferretti J. Abnormal glucose handling by the kidney in response to hypoglycemia in type 1 diabetes. Diabetes 2001; 50: 2087-2093
6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
7. Creyer PE. Hypoclycaemia is the limiting factor in the management of diabetes. Diabetes Metab Res Rev 1999; 15: 42-46
8. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
9. Gerich JE. Lilly Lecture 1988: glucose conterregulation and its impact on diabetes mellitus. Diabetes 1988; 37: 1608-1617
10. Gerich JE, Meyer C, Woerle HJ et al. Renal Gluconeogenesis. Its importance in human glucose homeostasis. Diabetes Care 2001; 24: 382-391
11. Hasslacher C. Safety and efficacy of repaglinide in type 2 diabetes patients with and without impaired renal unction. Diabetes Care (in press)
12. Herings RMC, de Boer A, Stricker BHC, Leufkens HGM, Presius A. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet 1995; 345: 1195-1198
13. Jönsson A, Rydberg T, Sterner G, Melander A. Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function. Eur J Clin Pharmacol 1998; 53: 429-435
14. Meyer C, Doston JM, Gerich JE. Role of the human kidney in glucose counterregulation. Diabetes 1999; 48: 943-948
15. Mühlhauser I, Toth G, Sawicki PT, Berger M. Severe hypoglycemia in type I diabetic patients with impaired kidney function. Diab Care 1991; 14: 344-346
16. Rabkin R, Ryan MP. Duckworth WC. The renal metabolism of insulin. Diabetologia 1984; 27: 351-357
17. Rave K, Heise T, Pfützner A, Heinemann L, Sawicki PT. Impact of diabetic nephropathy on pharmacodynamic and pharmacokinetic properties of insulin in type 1 diabetic patients. Diab Care 2001; 24: 886-890
18. Rett K, Wicklmayer M, Dietze J. Hypoglycaemia in hypertensive diabetic patients treated with sulfonylureas, biguanidines, and captopril. N Engl J Med 1988; 319: 1609
19. Rosenkranz R, Profozic V, Metelko Z, Mrzljak V, Lange C, Malerczyk V. Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment. Diabetologia 1996; 39: 1617-1624
20. Schumacher S, Abbasi I, Weise D, Hatorp V, Sattler K, Sieber J, Hasslacher C. Single- and multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment. Eur J Clin Pharmacol 2001; 57: 147-152
21. The EUCLID study group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787-1792
22. Stumvoll M, Meyer CA, Mitrakou C, Nadkarni V, Gerich JE. Renal glucose production and utilization: new aspects in humans. Diabetologia 1997; 40: 749-757
23. UKPDS (38). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 1998; 317: 703-713